TWST logo

TWST Twist Bioscience Corporation

NASDAQ Global Select · Biotechnology · Healthcare

$103.32
-8.30 (-7.44%)

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed fo…

Market Cap: $7.04Bwww.twistbioscience.com

Price

$115.67+104.00%
$49.17$71.34$93.50$115.67
Apr 29Aug 7

Social Signal Score

56
5d
57
1 mentions
+0.0%
30d
56
11 mentions
+0.0%
60d
56
16 mentions
+0.0%
90d
57
25 mentions
+0.0%
rss: 14 · 4chan: 5 · news: 6

Analyst Ratings

15 analysts
Buyconsensus
Strong Buy 0Buy 11Hold 2Sell 2Strong Sell 0
Avg price target$144.91+40.3%
Low $89Median $137High $215
Current Consensus

Revenue

$126.64M+3887.53%
$3.18M$44.33M$85.49M$126.64M
Jun 2017Sep 2026

Analyst Estimates

FY2026
$-2.15
$-2.16–$-2.14
5 analysts
FY2027
$-1.37
$-1.88–$-0.84
5 analysts
FY2028
$-0.94
$-0.99–$-0.90
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Emily Marine Leproust
Sector
Healthcare
Industry
Biotechnology
Employees
1,080
Beta
2.22
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
16.95
www.twistbioscience.com